Immune System Diseases

905 trials 381 recruiting

Filter these 905 trials by phase, country and sponsor.

Open in Search →

Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasth… Recruiting

2024-513854-31-00 Generalized Myasthenia Gravis 10 2021-10-27
TRIBECA - Multicenter randomized double-blind study comparing the efficacy and safety of belimumab in the treatment of non-infectious active… Recruiting

2024-516237-12-00 Cryoglobulinemia vasculitis 4 2021-10-20
Utvärdering av två kortison behandlingsstrategier hos patienter med nydiagnostiserad, tidigare obehandlad reumatoid artrit: en randomiserad,… Recruiting

2024-518775-54-00 Rheumatoid arthritis 6 2021-10-05
Clinical trial to asses the efficacy and safety of a vaccine for grasses and cupressaceae allergy Recruiting

2024-514524-16-00 Aetiological treatment of moderate-severe intermitent o 5 2021-05-11
A Phase 3 Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Deucravacitinib (BMS-986165) in Pediatric Subjects with Moderate to… Recruiting

2022-502519-13-00 Moderate to Severe Plaque Psoriasis 5 2021-05-07
Apremilast Study in Children with Active Juvenile Psoriatic Arthritis Recruiting

2023-503435-17-00 Juvenile psoriatic arthritis 5 2021-03-31
Open-label Phase 2 of tabelecleucel in Subjects with Epstein Barr Virus associated Diseases (EBVision) Recruiting

2024-516623-14-00 EBV+ primary imunodeficiency lymphoproliferative diseas 4 2021-03-17
An open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the i… Recruiting

2023-504417-67-00 Psoriatic Arthritis, Ankylosing Spondylitis, Non-radiog 6 2020-12-22
EFFECT OF ONCE VS TWICE DAILY ADMINISTRATION OF CORTICOSTEROIDS ON BLOOD GLUCOSE IN PATIENTS WITH ANCA-VASCULITIS MEASURED BY CONTINUOUS BLO… Recruiting

2024-516141-39-00 anti-neutrophil cytoplasmic antibody (ANCA)-associated 11 2020-09-25
SUBCUTANEOUS INJECTIONS OF AUTOLOGOUS CULTURED ADIPOSE-DERIVED STROMA/ STEM CELLS TO HEAL REFRACTORY ISCHEMIC DIGITAL ULCERS IN PATIENTS WIT… Recruiting

2023-508432-53-00 Systemic sclerosis 4 2020-09-22
An unblinded clinical Trial with random assignment to Treatment Groups in adult patients with psoriatic arthrits to evaluate how far immunos… Recruiting

2023-508251-39-00 Psoriatic arthritis 5 2020-09-18
An exploratory, randomized, double-blind, multicenter, placebo-controlled study to assess the safety, tolerability, pharmacokinetics, and ef… Recruiting

2024-518384-36-00 Idiopathic membranous nephropathy and severe proteinuri 4 2020-08-31
An experimental study in adults and adolescents who underwent stem cell transplantation and developed a Graft versus Host Disease after ster… Recruiting

2023-505737-26-00 Steroid refractory Acute Graft versus host Disease 5 2020-07-22
A Multicenter Randomized, Controlled, Double-blinded Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune … Recruiting

2024-514494-21-00 autoimmune encephalitis 4 2020-05-13
A phase I dose-escalation study testing the feasibility and the tolerance of infusion of a third party suicide gene-transduced anti-HLA-DPB1… Recruiting

2024-515504-39-00 Patients with hematological malignancies (Cf. inclusion 7 2020-02-09
Randomized, double-blind, placebo-controlled, multi-centre trial to evaluate the efficacy, safety and tolerability of oral treatment with li… Recruiting

2024-512104-19-00 Irritable Bowel Syndrome 6 2019-11-19
A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With sJIA Recruiting

2023-507883-38-00 Systemic Juvenile Idiopathic Arthritis 5 2019-11-18
A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Ante… Recruiting

2023-505811-18-00 Uveitis 5 2019-11-11
Long-term efficacy, safety and tolerability of LNP023 in C3G or IC-MPGN Recruiting

2023-509343-27-00 C3 Glomerulopathy or idiopathic immune-complex membrano 11 2019-10-28
Phase 3, Open-label Apremilast Pediatric Long-term Extension Study in Children with Oral Ulcers Associated With Behçet’s Disease or Juvenile… Recruiting

2023-503433-21-00 Behçet’s disease is a chronic, relapsing, multisystem i 5 2019-10-03
Evaluating, clinical and immunological effects of rituximab with cyclophosphamide compared to rituximab alone in AAV patients Recruiting

2023-507868-39-00 ANCA Vasculitis 6 2019-05-03
Allogeneic hematopoietic cell transplantation from HLA-matched donor after Flu-Mel-PTCy versus Flu-Mel-ATG reduced-intensity conditioning: a… Recruiting

2024-518568-11-00 Hematological malignancies confirmed histologically: - 4 2019-02-04
Long-Term Follow-up Protocol for Subjects Treated with Gene-Modified T cells. Recruiting

2023-504201-36-00 Defined by parent protocol. The study will enroll all a 10 2018-12-21
A randomized trial to investigate the reset of humoral autoimmunity by combining belimumab with rituximab in severe systemic lupus erythemat… Recruiting

2023-507867-20-00 Lupus Erythematosus, Systemic 10 2018-10-04